Extrawell Pharmaceutical Holdings Limited (0858.HK) News
Follow Extrawell Pharmaceutical Holdings Limited (0858.HK) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 2 public stories across 2 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.
L
BRIEF — Extrawell Pharmaceutical Proposes Share Consolidation Of 20 Shares Into 1 Share Of HK$0.20 Par Value
Oct 14 (Reuters) — Extrawell Pharmaceutical Holdings Ltd: Proposes Share Consolidation Of 20 Shares Into 1 Share Of Hk$0.20 Par Value Further company coverage: 0858.HK (reuters.briefs@thomsonreuters.com)
EQUITY | Oct 14, 2026, 01:06 PM UTC
L
BRIEF — Extrawell Pharmaceutical Says Mr. Wu Xiangyun Appointed As Executive Director
Oct 12 (Reuters) — Extrawell Pharmaceutical Holdings Ltd: Appoints Mr. Wu Xiangyun As Executive Director Effective 12 OCTOBER 2026 Further company coverage: 0858.HK (Reuters.Briefs@thomsonreuters.com;)
NEWS | Oct 12, 2026, 03:00 PM UTC